Nam G, Yoon C M, Kim E, Rhee C K, Kim J H, Shin J H, Kim S H
Biochemicals Research Center, Korea Institute of Science and Technology, Cheongryang, Seoul, South Korea.
Bioorg Med Chem Lett. 2001 Mar 12;11(5):611-4. doi: 10.1016/s0960-894x(00)00681-8.
The syntheses and in vitro evaluation of a new series of pyrido[2,3-d]pyrimidine-2,4-diones bearing substituents at C-3 and/or C-4 positions on the pyridine ring are described. Some of these compounds, especially 51 and 6f, were found to be potent phosphodiesterase 4 (PDE 4) inhibitors exhibiting improved ratio of PDE 4 inhibitory activity:rolipram binding assay (RBA).
描述了一系列在吡啶环的C-3和/或C-4位带有取代基的新型吡啶并[2,3-d]嘧啶-2,4-二酮的合成及体外评价。发现其中一些化合物,尤其是51和6f,是有效的磷酸二酯酶4(PDE 4)抑制剂,在PDE 4抑制活性与咯利普兰结合试验(RBA)中表现出改善的比率。